ITC Limited has informed the Exchange regarding Board meeting held on August 01, 2025.
ITC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ITC Limited reported Q1 FY26 standalone revenue from operations of ₹21,059 crores, up ~19.7% year-on-year from ₹17,593 crores, driven mainly by a sharp ~39% jump in Agri Business and steady growth in Cigarettes (+7.6%) and FMCG-Others (+5.2%). Despite the strong top-line, profit growth was muted — standalone PAT from continuing operations rose just 1.9% YoY to ₹4,912 crores, as segment profitability weakened in Paperboards (segment profit down ~38%) and FMCG-Others (segment profit down ~16.5%, with EBITDA falling from ₹619 cr to ₹546 cr). On a consolidated basis, revenue grew to ₹23,129 crores with PAT at ₹5,343 crores (~4.9% higher). Statutory auditors SRBC & Co LLP issued an unmodified limited review report. Key strategic moves include the acquisition of organic foods brand Sresta Natural Bioproducts (24 Mantra) as a wholly-owned subsidiary, a higher stake in Mother Sparsh Baby Care (39.47%), and board approval for amalgamating Sresta and Wimco into ITC. Hotels business remains classified as discontinued operations post-demerger effective January 1, 2025.
Revenue acceleration is positive, but the disconnect between strong topline growth and flat profitability could weigh on near-term sentiment, as investors watch for margin recovery in Paperboards and FMCG-Others. Strategic acquisitions in fast-growing natural and baby care segments strengthen the long-term non-tobacco FMCG story, and the hotels demerger keeps the continuing-operations picture cleaner for valuation.